drugset / Trial / NCT01103739

To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications

NCT01103739

Phase 1 Completed 24 enrolled Pfizer
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to quantify the effect of multiple doses of PF-04531083 on the pharmacokinetics (PK) of co-administered single dose simvastatin.

Timeline

Start
2010-03
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04531083 Small molecule 100 mg
Subject Simvastatin Small molecule 20 mg

Indications